Relapsed Acute Lymphoblastic Leukemia
7 clinical trials · Condition
◉ Watch Relapsed Acute Lymphoblastic Leukemia
| Record | Firm | Date |
|---|---|---|
| Palbociclib in Combo w/Chemotherapy in Peds Relapsed/Refractory Acute Lymphoblastic Leukemia (NCT04996160) | Tanja Andrea Gruber | 2021-07-09 |
| Study Evaluating the Efficacy and Safety With CD19CAR-T for Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT04012879) | Chinese PLA General Hospital | 2019-05-01 |
| Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL (NCT03349281) | Julio Barredo, MD | 2019-03-25 |
| Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia (NCT03575325) | H. Lee Moffitt Cancer Center and Research Institute | 2018-10-11 |
| Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia (NCT01743807) | Therapeutic Advances in Childhood Leukemia Consortium | 2014-03-26 |
| Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) (NCT00928200) | Therapeutic Advances in Childhood Leukemia Consortium | 2009-04-13 |
Track Relapsed Acute Lymphoblastic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.